Institute of Transplantation, Department of Cardiothoracic Surgery, Freeman Hospital, Newcastle upon Tyne, UK; Department of Adult Cardiac Surgery, Ochapowski Regional Hospital #1, Krasnodar, Russia; Division of Cardiac Surgery and Cardiology, Kuban State Medical University, Krasnodar, Russia; Institute of Cellular Medicine, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne...

A variety of arrhythmias can occur after heart transplantation (HTx). Hearts selected to be donated for HTx should be in good condition and generally beat in sinus rhythm (SR). Absence or loss of SR after HTx can be due to any reason and can lead to serious hemodynamic problems. Ischemia reperfusion injury, unbalanced serum electrolytes and re-warming of cold myocardial tissue are known to init...

centres in the USA, probably over 55 centres in Europe. The heart-lung transplant service at Papworth started in 1984, and next year in 1988 it is planned to do 35 heart lung transplants. The history begins with a Russian, Demikof who did an animal heart-lung transplant in 1946 and it survived two hours. Denton Cooley had a patient last 14 hours, Lillehei in 1969 had a patient with a few days s...

Over 40 years after the first successful heart transplant in humans, it remains the treatment of choice for a selected group of patients with advanced heart failure (HF), despite the considerable progress made in HF treatment. Improved medical therapy has doubled the life expectancy of patients with HF and left ventricular (LV) systolic dysfunction, while in some patients cardiac resynchronizat...

BACKGROUND Along the past few years the number of papers on heterotopic cardiac transplant has been very scarce in the medical literature, including at the international level; this is particularly true in reference to the long term follow-up of these patients and the reason which led to the presentation of our report. OBJECTIVE To report the initial clinical experience and late evolution of ...

In the present article, we review publications from the previous year in the following 3 areas: clinical cardiology, geriatric cardiology, and heart failure and transplantation. Among the new developments in clinical cardiology are several contributions from Spanish groups on tricuspid and aortic regurgitation, developments in atrial fibrillation, syncope, and the clinical characteristics of he...

Heart transplantation is the most effective therapy for patients with Stage D heart failure with a median life expectancy of ≈10 to 15 years. Unfortunately, many patients die on the waiting list hoping for a chance of survival. The life boat cannot rescue everyone. Over a decade, the donor pool has remained relatively stable, whereas the number of heart transplant candidates has risen. Potentia...

Abstract Background Heart transplantation (HTx) has progressed from an experimental therapy option to a well-established therapeutic for congenital heart disease (CHD) patients in end-stage failure, thus we can expect large number of people with CHD be evaluated HTx the next decades. Objective To create systematic review and meta-analysis regarding short-term long-term outcomes adults pediatric...

AIMS Heart transplantation (HTx) is the most effective therapy in patients with end-stage heart failure. Diabetes-related complications are relative contraindications for heart transplantation. The aim of our study was to analyse the impact of DM (diabetes mellitus) at the time of heart transplantation and new-onset post-transplantation DM on long-term survival. METHODS A retrospective databa...